| Literature DB >> 14505638 |
Jeffrey Clough1, Shaoqing Chen, Eric M Gordon, Corinne Hackbarth, Stuart Lam, Joaquim Trias, Richard J White, Gianpaolo Candiani, Stefano Donadio, Gabriella Romanò, Romeo Ciabatti, Jeffrey W Jacobs.
Abstract
Thiazole peptide GE2270 A (1) possesses potent antimicrobial activity against many gram-positive pathogens, including methicillin resistant Staphylococcus aureus (S. aureus, MRSA; MIC(90)=0.06 microg/mL) and vancomycin resistant Enterococcus spp. (VRE; MIC(90)=0.03 microg/mL); however its poor aqueous solubility has prohibited its development for the clinical treatment of infections. An integrated combinatorial and medicinal chemistry program was employed to identify derivatives of 1 that retain activity but possess greatly enhanced aqueous solubility.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14505638 DOI: 10.1016/s0960-894x(03)00811-4
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823